Predictive value and diagnostic accuracy of F-18-fluoro-deoxy-glucose positron emission tomography treated grade 1 and 2 follicular lymphoma

被引:56
作者
Bishu, Shrinivas
Quigley, Joanna M.
Bishu, Shreenath R.
Olsasky, Sarah M.
Stem, Richard A.
Shostrom, Valerie K.
Holdeman, Karen P.
Paknikar, Subash
Armitage, James O.
Hankins, Jordan H.
机构
[1] NIMH, Natl Inst Hlth, Bethesda, MD 20892 USA
[2] Univ Nebraska, Med Ctr, Coll Med, Lincoln, NE 68583 USA
[3] NW Univ, Dept Pathol, Evanston, IL 60208 USA
[4] Univ Nebraska, Med Ctr, Coll Publ Hlth, Lincoln, NE 68583 USA
[5] Univ Nebraska, Dept Radiol, Div Nucl Med, Lincoln, NE 68583 USA
[6] Creighton Univ, Med Ctr, Dept Radiol, Div Nucl Med, Omaha, NE 68178 USA
[7] Univ Nebraska, Med Ctr, Dept Med, Sect Oncol & Hematol, Lincoln, NE 68583 USA
关键词
follicular lymphoma grade 1; follicular lymphoma grade 2; PET; staging; therapeutic assessment;
D O I
10.1080/10428190701422059
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
F-18-fluoro-deoxy-glucose positron emission tomography (PET) is a powerful tool for the imaging of aggressive B-cell lymphomas. In contrast, there is relatively little data on PET in follicular lymphoma grade 1 (FL-1) and grade 2 (FL-2). In this manuscript, we present our findings utilizing PET in treated FL-1 and FL-2. A retrospective review of patients who underwent PET examinations at our institution produced 95 PET examinations among 31 patients with FL-1 and FL-2. PET was obtained at initial staging, mid-induction and post-treatment. Results were compared with clinical follow-up. PET had high sensitivity (95%) and specificity (88%) for lesion detection in treated FL-1 and FL-2. Abnormal foci in FL-1 and FL-2 had similar intensities. Post-induction PET positive patients had shorter mean progression free survivals compared with PET negative patients (p-value <= 0.001), post-salvage PET positive trended toward shorter mean response duration compared with negative patients (p-value: 0.09). Our results indicate that PET is accurate in the diagnostic assessment of treated FL-1 and FL-2 and, post- treatment PET positive patients are likely to relapse prior to PET negative patients.
引用
收藏
页码:1548 / 1555
页数:8
相关论文
共 35 条
[1]   Stage I and II follicular non-Hodgkin's lymphoma: Long-term follow-up of no initial therapy [J].
Advani, R ;
Rosenberg, SA ;
Horning, SJ .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (08) :1454-1459
[2]   Non-Hodgkin lymphoma: Diagnosis and treatment [J].
Ansell, SM ;
Armitage, J .
MAYO CLINIC PROCEEDINGS, 2005, 80 (08) :1087-1097
[3]   Staging non-Hodgkin lymphoma [J].
Armitage, JO .
CA-A CANCER JOURNAL FOR CLINICIANS, 2005, 55 (06) :368-376
[4]  
Aurora Vikas, 2006, Expert Opin Pharmacother, V7, P1273, DOI 10.1517/14656566.7.10.1273
[5]   What is remission in follicular lymphoma and what is its relevance? [J].
Buckstein, R ;
Pennell, N ;
Berinstein, NL .
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2005, 18 (01) :27-56
[6]  
Chan WC, 1997, BLOOD, V89, P3909
[7]   Revised response criteria for malignant lymphoma [J].
Cheson, Bruce D. ;
Pfistner, Beate ;
Juweid, Malik E. ;
Gascoyne, Randy D. ;
Specht, Lena ;
Horning, Sandra J. ;
Coiffier, Bertrand ;
Fisher, Richard I. ;
Hagenbeek, Anton ;
Zucca, Emanuele ;
Rosen, Steven T. ;
Stroobants, Sigrid ;
Lister, T. Andrew ;
Hoppe, Richard T. ;
Dreyling, Martin ;
Tobinai, Kensei ;
Vose, Julie M. ;
Connors, Joseph M. ;
Federico, Massimo ;
Diehl, Volker .
JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (05) :579-586
[8]  
DELBEKE D, 2006, PROCEDURE GUIDELINE
[9]   Patients with grade 3 follicular lymphoma have prolonged relapse-free survival following anthracycline-based chemotherapy: the Nebraska Lymphoma Study Group Experience [J].
Ganti, A. K. ;
Weisenburger, D. D. ;
Smith, L. M. ;
Hans, C. P. ;
Bociek, R. G. ;
Bierman, P. J. ;
Vose, J. M. ;
Armitage, J. O. .
ANNALS OF ONCOLOGY, 2006, 17 (06) :920-927
[10]   Gene expression profiling in follicular lymphoma to assess clinical aggressiveness and to guide the choice of treatment [J].
Glas, AM ;
Kersten, MJ ;
Delahaye, LJMJ ;
Witteveen, AT ;
Kibbelaar, RE ;
Velds, A ;
Wessels, LFA ;
Joosten, P ;
Kerkhoven, RM ;
Bernards, R ;
van Krieken, JHJM ;
Kluin, PM ;
van't Veer, LJ ;
de Jong, D .
BLOOD, 2005, 105 (01) :301-307